ACADIA Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $2.93 billion. The enterprise value is $2.51 billion.
| Market Cap | 2.93B |
| Enterprise Value | 2.51B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 165.22 million shares outstanding. The number of shares has increased by 2.69% in one year.
| Shares Outstanding | 165.22M |
| Shares Change (YoY) | +2.69% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 0.51% |
| Owned by Institutions (%) | 100.92% |
| Float | 107.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 22.83 |
| PS Ratio | 3.60 |
| Forward PS | 2.95 |
| PB Ratio | 6.32 |
| P/FCF Ratio | 46.06 |
| PEG Ratio | -0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 98.03, with an EV/FCF ratio of 39.36.
| EV / Earnings | n/a |
| EV / Sales | 3.08 |
| EV / EBITDA | 98.03 |
| EV / EBIT | 168.10 |
| EV / FCF | 39.36 |
Financial Position
The company has a current ratio of 2.04, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.04 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | 0.77 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.40%.
| Return on Equity (ROE) | -0.40% |
| Return on Assets (ROA) | -0.20% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1.36M |
| Profits Per Employee | -$2,860 |
| Employee Count | 598 |
| Asset Turnover | 1.13 |
| Inventory Turnover | 1.62 |
Taxes
In the past 12 months, ACAD has paid $16.62 million in taxes.
| Income Tax | 16.62M |
| Effective Tax Rate | 111.47% |
Stock Price Statistics
The stock price has decreased by -44.37% in the last 52 weeks. The beta is 0.38, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -44.37% |
| 50-Day Moving Average | 15.81 |
| 200-Day Moving Average | 21.26 |
| Relative Strength Index (RSI) | 62.32 |
| Average Volume (20 Days) | 1,795,695 |
Short Selling Information
The latest short interest is 11.93 million, so 7.22% of the outstanding shares have been sold short.
| Short Interest | 11.93M |
| Short Previous Month | 12.63M |
| Short % of Shares Out | 7.22% |
| Short % of Float | 11.08% |
| Short Ratio (days to cover) | 7.69 |
Income Statement
In the last 12 months, ACAD had revenue of $813.81 million and -$1.71 million in losses. Loss per share was -$0.01.
| Revenue | 813.81M |
| Gross Profit | 750.88M |
| Operating Income | -4.59M |
| Pretax Income | 14.91M |
| Net Income | -1.71M |
| EBITDA | 25.56M |
| EBIT | 14.91M |
| Loss Per Share | -$0.01 |
Balance Sheet
The company has $476.29 million in cash and $49.19 million in debt, giving a net cash position of $427.10 million or $2.59 per share.
| Cash & Cash Equivalents | 476.29M |
| Total Debt | 49.19M |
| Net Cash | 427.10M |
| Net Cash Per Share | $2.59 |
| Equity (Book Value) | 464.04M |
| Book Value Per Share | 2.81 |
| Working Capital | 344.70M |
Cash Flow
In the last 12 months, operating cash flow was $63.71 million and capital expenditures -$50,000, giving a free cash flow of $63.66 million.
| Operating Cash Flow | 63.71M |
| Capital Expenditures | -50,000 |
| Free Cash Flow | 63.66M |
| FCF Per Share | $0.39 |
Margins
Gross margin is 92.27%, with operating and profit margins of -0.56% and -0.21%.
| Gross Margin | 92.27% |
| Operating Margin | -0.56% |
| Pretax Margin | 1.83% |
| Profit Margin | -0.21% |
| EBITDA Margin | 3.14% |
| EBIT Margin | 1.83% |
| FCF Margin | 7.82% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.69% |
| Shareholder Yield | -2.69% |
| Earnings Yield | -0.06% |
| FCF Yield | 2.17% |
Analyst Forecast
The average price target for ACAD is $29.30, which is 65.07% higher than the current price. The consensus rating is "Buy".
| Price Target | $29.30 |
| Price Target Difference | 65.07% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 15.97% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 2.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.04 |
| Piotroski F-Score | 4 |